Format

Send to

Choose Destination
Eur Heart J. 2013 Mar;34(11):816-29. doi: 10.1093/eurheartj/ehs224. Epub 2012 Oct 25.

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives.

Author information

1
Department of Heart Diseases, Wroclaw Medical University, ul Weigla 5, 50-981 Wroclaw, Poland. ewa.jankowska@am.wroc.pl

Abstract

Iron is a micronutrient essential for cellular energy and metabolism, necessary for maintaining body homoeostasis. Iron deficiency is an important co-morbidity in patients with heart failure (HF). A major factor in the pathogenesis of anaemia, it is also a separate condition with serious clinical consequences (e.g. impaired exercise capacity) and poor prognosis in HF patients. Experimental evidence suggests that iron therapy in iron-deficient animals may activate molecular pathways that can be cardio-protective. Clinical studies have demonstrated favourable effects of i.v. iron on the functional status, quality of life, and exercise capacity in HF patients. It is hypothesized that i.v. iron supplementation may become a novel therapy in HF patients with iron deficiency.

PMID:
23100285
PMCID:
PMC3596759
DOI:
10.1093/eurheartj/ehs224
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center